Skip to content
Screener

R&D at other companies

CONMED logo
CONMEDCNMD
$15.5M+9.6%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$323M+7.0%
Telos Corporation logo
Telos CorporationTLS
$1.36M-13.6%
nLIGHT, Inc. logo
nLIGHT, Inc.LASR
$13.13M+19.2%
Viavi Solutions Inc. logo
Viavi Solutions Inc.VIAV
$71M+42.0%
MKS Instruments logo
MKS InstrumentsMKSI
$76M0.0%

Segments

By segment

See full
Security Division$13.55M+4.2%
Healthcare Division$4.63M+7.7%
Optoelectronics And Manufacturing Division$1.28M+0.9%

Other financials

Income statement

See full
Revenue$453.2M+2.0%
Gross profit$150.3M0.0%
Operating income$53.2M-5.3%
Net income$40.2M-2.2%
EPS (diluted)$2.33-2.9%

Balance sheet

See full
Cash & equivalents$345.2M+260%
Total debt$1.0B+107%
Total equity$894.3M+1.7%
Total assets$2.6B+22.8%

Cash flow

See full
Operating cash flow$14.5M-82.3%
CapEx$7.6M+67.3%
Free cash flow$6.9M-91.1%

Valuation

See full
Market cap$3.91B+5.3%
Enterprise value$4.61B+12.1%
P/E25.7×+0.9×
P/S2.2×0.0×

Profitability

See full
Gross margin32.8%-1.1pp
Operating margin12.1%-0.2pp
Net margin8.4%0.0pp
FCF margin4%+1.5pp

Returns & leverage

See full
Return on equity17.2%+0.4pp
Debt / equity1.2×+0.6×
Current ratio3.2×+1.1×

Where this comes from

Reported directly by OSI Systems in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: OSI Systems’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 5:24 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-055014
Line itemThree Months Ended March 31, 2025Three Months Ended March 31, 2026Nine Months Ended March 31, 2025Nine Months Ended March 31, 2026
Gross profit150,291150,324418,944425,138
Operating expenses:
Selling, general and administrative73,24971,487216,194208,643
Research and development18,57019,45554,60059,641
Impairment, restructuring and other charges2,2556,1683,64811,772
Total operating expenses94,07497,110274,442280,056
Income from operations56,21753,214144,502145,082
Interest and other expense, net(8,228)(3,995)(24,206)(22,106)

Item 1. Financial Statements (Unaudited)

FAQ

What is OSI Systems's R&D?
OSI Systems (OSIS) reported R&D of $19.46M in Q1 2026.
How has OSI Systems's R&D changed year-over-year?
OSI Systems's R&D increased by 4.8% year-over-year, from $18.57M to $19.46M.
What is the long-term trend for OSI Systems's R&D?
Over 3 years (2022 to 2025), OSI Systems's R&D has grown at a 7.2% compound annual growth rate (CAGR), from $59.58M to $73.44M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about OSI Systems's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude